Latest 10-K annual reports

NASDAQ
Resources Connection, Inc. (RGP) reported a net loss of $191.8 million for fiscal year 2025, primarily driven by a $194.4 million goodwill impairment charge and a significant decrease in revenue.
NASDAQ
Cintas Corporation announced significant financial achievements for fiscal year 2025, including a 7.7% increase in total revenue to $10.3 billion and a 16.1% rise in diluted earnings per share to $4.40, driven by strong organic growth and operational efficiencies.
FiEE, Inc. has filed an amended annual report for 2023, restating financial statements due to errors in common stock reporting, revealing a substantial going concern doubt, and highlighting significant inventory control challenges.
Tribal Rides International Corp. filed an amended annual report for 2023, disclosing persistent financial losses, a going concern warning, and material weaknesses in internal controls, alongside a recent change in executive leadership.
AMEX
Kairos Pharma, Ltd. filed an amendment to its 2024 Annual Report to include detailed information on executive compensation, corporate governance, and related party transactions, ensuring SEC compliance.
NASDAQ
TeraWulf Inc. filed an amendment to its 2024 Annual Report on Form 10-K to include previously omitted language regarding internal control over financial reporting in its Section 302 certifications.
CEA Industries Inc. reports increased revenue and backlog for the four months ended April 30, 2025, driven by a large equipment contract, but faces a growing net loss and significant going concern uncertainty following its strategic acquisition of Canadian vape retailer Fat Panda.
OQB
CytoDyn Inc. announced a net income of $3.7 million for fiscal year 2025, primarily due to a $25.0 million legal settlement, as it refocuses its clinical development on solid-tumor oncology while facing significant liquidity challenges and ongoing regulatory investigations.
NYSE
AMREP Corporation announced a significant increase in net income and diluted earnings per share for fiscal year 2025, driven by improved land sale margins and a tax benefit, despite a slight overall revenue decline and ongoing challenges in the homebuilding sector.
23andMe Holding Co. filed an amended annual report to include executive compensation and corporate governance details, confirming its delisting from Nasdaq and ongoing Chapter 11 bankruptcy proceedings.
NASDAQ
Scholastic Corporation recorded a net loss of $1.9 million for fiscal year 2025, a significant decline from the prior year's net income, despite a 2.3% revenue increase driven by the acquisition of 9 Story Media Group and strong performance in its Children's Book Publishing and Distribution segment.
OTC.Pink
Acro Biomedical Co., Ltd. filed its 2024 annual report, revealing no revenue, significant losses, and substantial doubt about its ability to continue as a going concern.
AMEX
Ocean Power Technologies, a maritime domain awareness company, reported increased revenue and a significant rise in backlog for fiscal year 2025, driven by strategic international expansion and new capital infusions, despite continued net losses.
Yijia Group Corp. announced significantly increased revenues and net income for fiscal year 2025, primarily fueled by the rapid expansion of its healthcare products segment, despite ongoing internal control deficiencies.
Zynex, Inc. filed an amended annual report detailing a temporary payment suspension from Tricare, a 10% staff reduction, and identified material weaknesses in internal controls, despite achieving revenue growth and its ninth consecutive profitable year.
NASDAQ
HeartSciences Inc. reported a significant increase in net losses for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, while actively pursuing FDA clearances for its AI-ECG devices and addressing Nasdaq listing requirements.
NYSE
RPM International Inc. reported increased net sales and diluted earnings per share for fiscal year 2025, driven by strategic acquisitions and the benefits of its MAP 2025 restructuring program, despite facing challenges in certain segments and significant legal liabilities.
Sonder Holdings Inc. reported a reduced net loss and improved Adjusted Free Cash Flow for fiscal year 2024, driven by portfolio optimization and a strategic integration with Marriott, yet management expressed substantial doubt about the company's ability to continue as a going concern.
Aquaron Acquisition Corp. filed an amended annual report clarifying disclosures and updating auditor opinion, while detailing its recent Nasdaq delisting and ongoing $1.0 billion merger agreement with Huture Ltd.
NASDAQ
Champions Oncology, a technology-enabled research organization, announced a significant financial turnaround in fiscal year 2025, achieving net income and positive cash flow from operations driven by increased revenue from research services and new data licensing.
OTC.Pink
Arogo Capital Acquisition Corp. reported a significant net loss, delisted from Nasdaq, terminated two prior merger agreements, and extended its business combination deadline to June 2026, while pursuing a new merger with Thailand-based telecommunications provider Tellink.
NYSE
Lamb Weston Holdings, Inc. reported a decline in net income and Adjusted EBITDA for fiscal year 2025, driven by increased costs and competitive market pressures, while announcing a new strategic plan to drive future efficiencies.
OID
MAG Magna Corp's latest 10-K filing reveals significant revenue growth driven by new API services, but also escalating net losses, a substantial accumulated deficit, and a recent change in control with a new CEO and loan forgiveness.
Triumph Group, Inc. filed an amendment to its Annual Report on Form 10-K to include detailed information on executive compensation, corporate governance, and security ownership for the fiscal year ended March 31, 2025.
NASDAQ
Alzamend Neuro's latest 10-K filing reveals significant financial challenges, including recurring losses and a going concern opinion, alongside a major delay in its ALZN002 Alzheimer's clinical trial, despite progress with its AL001 program.
NASDAQ
Cal-Maine Foods, the largest U.S. shell egg producer, announced a significant increase in net sales and net income for fiscal year 2025, driven by higher egg prices and strategic acquisitions, despite ongoing challenges from avian influenza and legal proceedings.
Guochun International Inc. filed its 2024 annual report, revealing no revenue, increased net losses, and substantial doubt about its ability to continue as a going concern, while actively seeking new business opportunities.
OTC.Pink
IMA Tech, an AI-driven digital avatar company, reported a net loss of $55,071 for fiscal year 2025 despite significant revenue growth, facing substantial doubt about its going concern status.
NYSE
AAR CORP. announced a substantial increase in fiscal 2025 sales and operating income, driven by robust commercial aviation demand and strategic acquisitions, despite incurring significant charges from an FCPA settlement and a business divestiture.
OTC.Pink
Old Market Capital Corporation filed an amendment to its annual report, clarifying disclosures and adding exhibits that include new rights of first refusal for its subsidiary Amplex Electric on two Ohio properties and the employment agreement for a new Assistant Controller.